✦ LIBER ✦

SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR

✍ Scribed by Levine, MyronM.; Herrington, Deirdre; Losonsky, Genevieve; Tall, Ben; Kaper, JamesB.; Ketley, Julian; Tacket, CarolO.; Cryz, Stanley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biosafety aspects of the recombinant liv

✍ Jean-François Viret; Guido Dietrich; Didier Favre 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Safety and immunogenicity of single-dose

✍ Suharyono, ; Simanjuntak, C; Totosudirjo, H; Witham, N; Punjabi, N; Burr, D; Sor 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 935 KB

Further molecular characterization and s

✍ Didier Favre; Mark-Michael Struck; Stanley J. Cryz Jr; Jean-François Viret 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 934 KB

Efficacy trial of single-dose live oral

✍ Emily Richie; Narain H Punjabi; Yuwono Sidharta; Kenny Peetosutan; Melanie Sukan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Randomized double-blind placebo controll

✍ S.J. Cryz Jr.; M.M. Levine; J.B. Kaper; E. Fürer; B. Althaus 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 393 KB

Atovaquone/proguanil does not affect imm

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 152 KB